Close
Back to VTRS Stock Lookup

(VTRS) –

Jul 19, 2024 04:53 AM Jefferies Resumes Viatris (VTRS) at Buy
Jul 3, 2024 08:41 AM Form 8-K Viatris Inc For: Jul 03
Jul 3, 2024 08:31 AM Viatris Inc (VTRS) Completes All Previously Announced Divestitures
Jul 3, 2024 08:30 AM Viatris Brings to Completion All Previously Announced Divestitures With the Closing of its Over-the-Counter Business Divestiture
Jul 2, 2024 07:30 AM Viatris Inc (VTRS) : U.S. Department of Justice Informs Viatris That It No Longer Considers Mylan a Subject of Generic Drug Industry Antitrust Investigation
Jul 2, 2024 07:30 AM U.S. Department of Justice Informs Viatris That It No Longer Considers Mylan a Subject of Generic Drug Industry Antitrust Investigation
Jun 25, 2024 05:25 PM Viatris Named to TIME’s World’s Most Sustainable Companies 2024 List
Jun 25, 2024 11:00 AM Viatris Named to TIME's World's Most Sustainable Companies 2024 List
Jun 17, 2024 06:00 PM Form 4 Viatris Inc For: Jun 13 Filed by: Malik Rajiv
Jun 13, 2024 12:06 PM Form 144 Viatris Inc Filed by: Malik Rajiv
Jun 7, 2024 06:59 AM Viatris to Report Second Quarter 2024 Financial Results on August 8, 2024
Jun 4, 2024 06:05 PM Form 4 Viatris Inc For: Jun 03 Filed by: Vivaldi Coelho Rogerio
Jun 4, 2024 06:00 PM Form 3 Viatris Inc For: Jun 03 Filed by: Vivaldi Coelho Rogerio
Jun 4, 2024 06:59 AM Viatris to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
Jun 3, 2024 07:16 AM Form 8-K Viatris Inc For: Jun 03
Jun 3, 2024 06:59 AM Viatris Inc (VTRS) Appoints Rogerio Vivaldi Coelho to its Board
Jun 3, 2024 06:59 AM Viatris Appoints Rogerio Vivaldi Coelho, M.D., to Board of Directors
May 31, 2024 06:59 AM Viatris to Participate in the Jeffries Global Healthcare Conference
May 28, 2024 06:00 PM Form 4 Viatris Inc For: May 28 Filed by: Roman Brian
May 28, 2024 04:11 PM Form 144 Viatris Inc Filed by: Roman Brian
May 28, 2024 10:06 AM Increasing unusual put option volume: INDA INSM GPN CCI DLO CORT GME INMD VTRS
May 21, 2024 06:30 PM Viatris Publishes 2023 Sustainability Report: Building Sustainable Access at Scale
May 21, 2024 06:59 AM Viatris Publishes 2023 Sustainability Report: Building Sustainable Access at Scale
May 21, 2024 12:50 AM Idorsia announces financial results for the first quarter 2024 – advancing the company with renewed vigor
May 9, 2024 04:05 PM Form 10-Q Viatris Inc For: Mar 31
May 9, 2024 07:44 AM Form 8-K Viatris Inc For: May 09
May 9, 2024 07:01 AM Viatris Inc (VTRS) Reports In-Line Q1 EPS; offers guidance
May 9, 2024 06:59 AM Viatris Reports Strong First Quarter 2024 Financial Results and Reaffirms 2024 Financial Guidance Ranges
May 2, 2024 05:00 PM Viatris to Participate in the BofA Securities 2024 Health Care Conference
May 1, 2024 06:30 PM Viatris Expands Its Wellbeing Program With the Launch of Unmind, a Leading Workplace Resource Focused on Mental Health
May 1, 2024 06:59 AM Viatris Inc (VTRS) Launches Unmind
May 1, 2024 06:59 AM Viatris Expands its Wellbeing Program with the Launch of Unmind, a Leading Workplace Resource Focused on Mental Health
Apr 26, 2024 04:32 PM Form 10-K/A Viatris Inc For: Dec 31
Apr 19, 2024 06:05 PM Form 4 Viatris Inc For: Apr 18 Filed by: Le Goff Corinne
Apr 19, 2024 06:00 PM Form 3 Viatris Inc For: Apr 15 Filed by: Le Goff Corinne
Apr 16, 2024 04:30 PM Viatris to Report First Quarter 2024 Financial Results on May 9, 2024
Apr 15, 2024 08:00 AM Viatris Inc (VTRS) Appoints Corinne Le Goff as Chief Commercial Officer
Apr 15, 2024 08:00 AM Viatris Appoints Corinne Le Goff as Chief Commercial Officer
Apr 4, 2024 06:00 PM Form 4 Viatris Inc For: Apr 02 Filed by: Malik Rajiv
Apr 1, 2024 07:15 AM Ocuphire Pharma (OCUP) Announces US Launch of RYZUMVl
Apr 1, 2024 07:14 AM Ocuphire Announces the U.S. Commercial Launch of RYZUMVl™ (Phentolamine Ophthalmic Solution 0.75%) by its Partner Viatris
Apr 1, 2024 06:59 AM Viatris Inc (VTRS) Announces Launch of RYZUMVl in the US
Apr 1, 2024 06:59 AM Viatris Announces the Launch of RYZUMVl™ (Phentolamine Ophthalmic Solution) 0.75% in the United States
Mar 28, 2024 06:48 AM Viatris (VTRS) PT Raised to $13 at Piper Sandler on latest Idorsia deals
Mar 27, 2024 06:59 AM Viatris Hosts R&D Event Focusing on its Collaboration with Idorsia, Phase 3 Assets Selatogrel and Cenerimod and Key Elements of its Pipeline
Mar 18, 2024 02:00 AM Idorsia and Viatris successfully close the transaction for the global research and development collaboration
Mar 15, 2024 06:01 PM Form 4 Viatris Inc For: Mar 13 Filed by: Mauro Anthony
Mar 11, 2024 10:37 AM Form 144 Viatris Inc Filed by: Mauro Anthony
Mar 5, 2024 08:37 PM Form 4 Viatris Inc For: Mar 02 Filed by: Campbell Paul
Mar 5, 2024 08:36 PM Form 4 Viatris Inc For: Mar 02 Filed by: Mauro Anthony

Back to VTRS Stock Lookup